The Veteran's prostate cancer residuals with voiding dysfunction are rated at 60 percent, effective August 12, 2023. A separate 30 percent rating is granted for bowel incontinence residuals of prostate cancer.,On and after August 12, 2023, the Veteran is granted a TDIU based on his service-connected disabilities.,Effective August 12, 2023, the Veteran is also granted SMC at the housebound rate due to his service-connected disabilities.
The deciding factor: The Veteran's prostate cancer residuals with voiding dysfunction are rated at 60 percent under Diagnostic Code 7528. A separate 30 percent rating for bowel incontinence residuals of prostate cancer is granted based on the criteria for bowel incontinence (DC 7332). The TDIU and SMC were granted effective August 12, 2023, as these disabilities meet the schedular requirements.
- Claimed conditions
- prostate cancer residuals with voiding dysfunction, bowel incontinence residuals of prostate cancer
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- 60%
- Decision date
- December 19, 2024
- Citation
- A24085309
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation A24085309.
What this means for you
A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Partly granted
The Board granted service connection for adjustment disorder with depressed mood and a headache disability, as secondary to the Veteran's service-connected prostate cancer residuals. The Board also granted an increased rating of 60 percent for prostate cancer residuals with voiding dysfunction effective September 29, 2023.
- Partly granted
The veteran's claim for erectile dysfunction and special monthly compensation was granted effective February 24, 2020. The appeals regarding proposed rating reductions were dismissed.
- Denied
The Board denied the Veteran's appeal to reinstate a 100 percent rating for prostate cancer residuals and special monthly compensation (SMC) at the statutory housebound rate, effective December 1, 2023.
- Remanded (sent back)
The Veteran's claims for increased evaluations of his service-connected diabetes mellitus, prostate cancer residuals with voiding dysfunction, and erectile dysfunction are being remanded due to the need for additional examinations and treatment records.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.